Molecular basis for specificity in the druggable kinome: sequence-based analysis

被引:29
作者
Chen, Jianping
Zhang, Xi
Fernandez, Ariel [1 ]
机构
[1] Rice Univ, Program Appl Phys, Houston, TX 77005 USA
[2] Rice Univ, Rice Quantum Inst, Houston, TX 77005 USA
[3] Rice Univ, Dept Bioengn, Houston, TX 77005 USA
[4] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA
关键词
D O I
10.1093/bioinformatics/btl666
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Motivation: Rational design of kinase inhibitors remains a challenge partly because there is no clear delineation of the molecular features that direct the pharmacological impact towards clinically relevant targets. Standard factors governing ligand affinity, such as potential for intermolecular hydrophobic interactions or for intermolecular hydrogen bonding do not provide good markers to assess cross reactivity. Thus, a core question in the informatics of drug design is what type of molecular similarity among targets promotes promiscuity and what type of molecular difference governs specificity. This work answers the question for a sizable screened sample of the human pharmacokinome including targets with unreported structure. Results: We show that drug design aimed at promoting pairwise interactions between ligand and kinase target actually fosters promiscuity because of the high conservation of the partner groups on or around the ATP-binding site of the kinase. Alternatively, we focus on a structural marker that may be reliably determined from sequence and measures dehydration propensities mostly localized on the loopy regions of kinases. Based on this marker, we construct a sequence-based kinase classifier that enables the accurate prediction of pharmacological differences. Our indicator is a micro-environmental descriptor that quantifies the propensity for water exclusion around preformed polar pairs. The results suggest that targeting polar dehydration patterns heralds a new generation of drugs that enable a tighter control of specificity than designs aimed at promoting ligand-kinase pairwise interactions. Availability: The predictor of polar hot spots for dehydration propensity, or solvent-accessible hydrogen bonds in soluble proteins, named YAPView, may be freely downloaded from the University of Chicago website http://protlib.uchicago.edu/dloads.html Contact: arifer@rice.edu, ariel@uchicago.edu Supplementary information: Supplementary data are available at Bioinformatics online.
引用
收藏
页码:563 / 572
页数:10
相关论文
共 27 条
  • [1] The specificities of protein kinase inhibitors: an update
    Bain, J
    McLauchlan, H
    Elliott, M
    Cohen, P
    [J]. BIOCHEMICAL JOURNAL, 2003, 371 : 199 - 204
  • [2] De novo prediction of three-dimensional structures for major protein families
    Bonneau, R
    Strauss, CEM
    Rohl, CA
    Chivian, D
    Bradley, P
    Malmström, L
    Robertson, T
    Baker, D
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2002, 322 (01) : 65 - 78
  • [3] Combining prediction, computation and experiment for the characterization of protein disorder
    Bracken, C
    Iakoucheva, LM
    Rorner, PR
    Dunker, AK
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2004, 14 (05) : 570 - 576
  • [4] Prediction of CASP6 structures using automated Robetta protocols
    Chivian, D
    Kim, DE
    Malmström, L
    Schonbrun, J
    Rohl, CA
    Baker, D
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 61 : 157 - 166
  • [5] HYDROPHOBIC BONDING AND ACCESSIBLE SURFACE-AREA IN PROTEINS
    CHOTHIA, C
    [J]. NATURE, 1974, 248 (5446) : 338 - 339
  • [6] Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo
    Dietz, AB
    Souan, L
    Knutson, GJ
    Bulur, PA
    Litzow, MR
    Vuk-Pavlovi, S
    [J]. BLOOD, 2004, 104 (04) : 1094 - 1099
  • [7] Molecularly targeted Therapy: Have the floodgates opened?
    Druker, BJ
    [J]. ONCOLOGIST, 2004, 9 (04) : 357 - 360
  • [8] Escriva H, 2000, BIOESSAYS, V22, P717
  • [9] A small molecule-kinase interaction map for clinical kinase inhibitors
    Fabian, MA
    Biggs, WH
    Treiber, DK
    Atteridge, CE
    Azimioara, MD
    Benedetti, MG
    Carter, TA
    Ciceri, P
    Edeen, PT
    Floyd, M
    Ford, JM
    Galvin, M
    Gerlach, JL
    Grotzfeld, RM
    Herrgard, S
    Insko, DE
    Insko, MA
    Lai, AG
    Lélias, JM
    Mehta, SA
    Milanov, ZV
    Velasco, AM
    Wodicka, LM
    Patel, HK
    Zarrinkar, PP
    Lockhart, DJ
    [J]. NATURE BIOTECHNOLOGY, 2005, 23 (03) : 329 - 336
  • [10] High-throughput assays for promiscuous inhibitors
    Feng, BY
    Shelat, A
    Doman, TN
    Guy, RK
    Shoichet, BK
    [J]. NATURE CHEMICAL BIOLOGY, 2005, 1 (03) : 146 - 148